A
Anne Hersey
Researcher at European Bioinformatics Institute
Publications - 58
Citations - 13515
Anne Hersey is an academic researcher from European Bioinformatics Institute. The author has contributed to research in topics: chEMBL & Intestinal absorption. The author has an hindex of 33, co-authored 57 publications receiving 10434 citations. Previous affiliations of Anne Hersey include Biomet & University College London.
Papers
More filters
Journal ArticleDOI
ChEMBL: a large-scale bioactivity database for drug discovery
Anna Gaulton,Louisa J. Bellis,A. Patrícia Bento,Jon Chambers,Mark Davies,Anne Hersey,Yvonne Light,Shaun McGlinchey,David Michalovich,Bissan Al-Lazikani,John P. Overington +10 more
TL;DR: ChEMBL is an Open Data database containing binding, functional and ADMET information for a large number of drug-like bioactive compounds to maximize their quality and utility across a wide range of chemical biology and drug-discovery research problems.
Journal ArticleDOI
The ChEMBL database in 2017.
Anna Gaulton,Anne Hersey,Michal Nowotka,A. Patrícia Bento,Jon Chambers,David Mendez,Prudence Mutowo,Francis Atkinson,Louisa J. Bellis,Elena Cibrian-Uhalte,Mark Davies,Nathan Dedman,Anneli Karlsson,María Paula Magariños,John P. Overington,George Papadatos,Ines Smit,Andrew R. Leach +17 more
TL;DR: ChEMBL is an open large-scale bioactivity database that includes the annotation of assays and targets using ontologies, the inclusion of targets and indications for clinical candidates, addition of metabolic pathways for drugs and calculation of structural alerts.
Journal ArticleDOI
A comprehensive map of molecular drug targets
Rita Santos,Rita Santos,Oleg Ursu,Anna Gaulton,A. Patrícia Bento,Ramesh S. Donadi,Cristian Bologa,Anneli Karlsson,Bissan Al-Lazikani,Anne Hersey,Tudor I. Oprea,John P. Overington +11 more
TL;DR: An updated comprehensive map of molecular targets of approved drugs is presented and the relationships between bioactivity class and clinical success, as well as the presence of orthologues between human and animal models and between pathogen and human genomes are explored.
Journal ArticleDOI
The ChEMBL bioactivity database: an update
A. Patrícia Bento,Anna Gaulton,Anne Hersey,Louisa J. Bellis,Jon Chambers,Mark Davies,Felix A. Kruger,Yvonne Light,Lora Mak,Shaun McGlinchey,Michal Nowotka,George Papadatos,Rita Santos,John P. Overington +13 more
TL;DR: More comprehensive tracking of compounds from research stages through clinical development to market is provided through the inclusion of data from United States Adopted Name applications and a new richer data model for representing drug targets has been developed.
Journal ArticleDOI
ChEMBL: towards direct deposition of bioassay data
David Mendez,Anna Gaulton,A. Patrícia Bento,Jon Chambers,Marleen De Veij,Eloy Felix,María Paula Magariños,Juan F Mosquera,Prudence Mutowo,Michal Nowotka,María Gordillo-Marañón,Fiona M. I. Hunter,Laura Junco,Grace Mugumbate,Milagros Rodríguez-López,Francis Atkinson,Nicolas Bosc,Chris J Radoux,Aldo Segura-Cabrera,Anne Hersey,Andrew R. Leach +20 more
TL;DR: Several important improvements have been made to ChEMBL in the last two years, including more robust capture and representation of assay details; a new data deposition system, allowing updating of data sets and deposition of supplementary data; and a completely redesigned web interface, with enhanced search and filtering capabilities.